Seeking Alpha's chart breakdown of Lilly's third quarter puts Mounjaro at $10.7B in sales. Only the headline figures come through here.
Recap by typeshit. Full story at TradingView.
The chain says it is exploring concepts including grilled items aimed at GLP-1 users, a sign of how the drugs are shifting food businesses.
Ahead of results, Kalkine looks at how costly late-stage trials for Amgen's monthly obesity shot MariTide weigh on the outlook.
A short post says demand for GLP-1s, psychedelics and testosterone is meeting commercial interests, calling it a big shift.
A beauty take that waves off pricey LA peptide and salmon sperm serums, saying better anti-aging habits are found closer to home.
In an exclusive interview, the former NBA star describes the change in his life as night and day. Tap through for how he talks about it.
The FDA approved weekly insulin Awiqli for children 10 and up with type 2 diabetes, while Lilly's retatrutide data adds pressure before Novo's nine-month numbers.
Loading…